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In contrast to male rats, aggression in virgin female rats has been rarely studied. Here, we
established a rat model of enhanced aggression in females using a combination of social
isolation and aggression-training to specifically investigate the involvement of the oxytocin
(OXT) and arginine vasopressin (AVP) systems within the lateral septum (LS). Using neu-
ropharmacological, optogenetic, chemogenetic as well as microdialysis approaches, we
revealed that enhanced OXT release within the ventral LS (vLS), combined with reduced AVP
release within the dorsal LS (dLS), is required for aggression in female rats. Accordingly,
increased activity of putative OXT receptor-positive neurons in the vLS, and decreased
activity of putative AVP receptor-positive neurons in the dLS, are likely to underly aggression
in female rats. Finally, in vitro activation of OXT receptors in the vLS increased tonic
GABAergic inhibition of dLS neurons. Overall, our data suggest a model showing that septal
release of OXT and AVP differentially affects aggression in females by modulating the
inhibitory tone within LS sub-networks.
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Aggressive behavior is expressed by most, if not all, mam-malian species, including humans. Typically, aggression isdisplayed whenever conspecifics have to compete for
resources, such as food, territory, or mating partners1. When
expressed out-of-context or in an exacerbated manner, aggressive
behavior becomes disruptive and harms both aggressor and vic-
tim. In humans, excessive or pathological aggression as seen, for
example, in individuals suffering from conduct or antisocial
personality disorder constitutes a severe burden to society1,2. To
better understand the neurobiology of aggression and to develop
potential treatment options, laboratory animal models of
aggression have been successfully used for decades1,3,4. However,
these models were mostly developed in male rodents, whereas
females have been rather understudied, except during the phy-
siologically unique period of lactation5. Given the fact that (i)
females demonstrate disruptive aggression similarly to males6–8,
and (ii) the neurobiology of aggression appears to be sex-
dimorphic5,8–11, the use of non-lactating female animal models is
required to increase our understanding of the neurobiology
aggression in females and to identify potential targets for the
treatment of pathological aggression in both sexes.
In order to study the neurobiological mechanisms underlying
the aggression of virgin female Wistar rats (defined here as female
aggression), we first established an animal model to robustly
enhance their mild levels of aggression12. We predicted that a
combination of social isolation and aggression-training by repe-
ated exposure to the female intruder test (FIT)12, i.e., to an
unknown same-sex intruder, enhances female aggressiveness, as
both social isolation11,13 and repeated engagement in conflict
with conspecifics (“winner effect”)14–16 exacerbate aggression in
solitary and aggressive rodent species, independent of sex.
Next, we investigated the role of oxytocin (OXT) and arginine
vasopressin (AVP) in the aggressive behavior displayed by female
Wistar rats. Both neuropeptides have been associated with var-
ious social behaviors including aggression in males and lactating
females17–24, and are known to be affected by social isolation in a
sex-dependent manner11,13. In this context, we hypothesized that
the effects of OXT and AVP on the aggression expressed by
female rats are predominantly mediated in the lateral septum (LS)
—a target region for neuropeptide actions24 and known to sup-
press aggression in both sexes10,25. Electrical stimulation of the
LS26,27, and more specifically optogenetic stimulation of septal
GABAergic projections to the ventromedial nucleus of the
hypothalamus (VMH)28, reduces aggression in male rodents. In
contrast, pharmacological inhibition or lesioning of the LS trig-
gers exaggerated aggression (“septal rage”) in male and female
hamsters10,29,30.
Although several pieces of evidence point towards the gating
role of the LS in aggression, the underlying mechanisms, espe-
cially the involvement of septal OXT and AVP in aggression
displayed by female rats, are still unknown. The release of both
neuropeptides in the LS has been tied to various social behaviors,
including intermale aggression, although the results are somewhat
conflicting24. For example, in male Wistar rats, attenuated21, as
well as increased22 AVP release, have been described during the
display of abnormal and high31 aggression, respectively.
Regarding the role of the septal OXT system, increased OXT
receptor (OXTR) binding has been reported in both dominant
male mice32 and lactating female rats33. Importantly, rats have a
markedly specific expression of OXTRs and AVP V1a receptors
(V1aRs) in two distinct subregions of the LS, i.e., OXTRs are
exclusively found in the ventral LS (vLS), whereas V1aRs are
predominantly found in the dorsal LS (dLS)34.
Here, using a reliable rat model of female aggression, we first
compared central release patterns of endogenous OXT and AVP
between low-aggressive (group-housed; GH) and high-aggressive
(isolated and trained; IST) rats by measuring neuropeptide con-
tent in microdialysates sampled within the LS or in the cere-
brospinal fluid (CSF), during or after exposure to the FIT,
respectively. In addition, we assessed septal OXTR and V1aR
binding in GH and IST females. Next, we employed pharmaco-
logical, chemogenetic, and optogenetic approaches to selectively
manipulate central OXT or AVP signaling, specifically in the vLS
or dLS, and studied their behavioral consequences in the FIT.
Finally, to specifically dissect the neuronal mechanisms within the
LS controlling aggressive behavior, we activated septal OXTRs
and V1aRs, while recording spontaneous GABAergic inputs to
the vLS and dLS GABAergic neurons in vitro, and monitored as
well as locally manipulated neuronal activity in rats with opposite
levels of aggression in vivo.
Results
Social isolation and training reliably enhance aggression in
female rats. Training consisted of daily 10-min exposure to a
FIT12 on 3 consecutive days. GH and isolated non-trained rats
(IS) were used as control groups to assess the effects of social
isolation and aggression-training, i.e., repeated exposure to FIT
over 3 days, respectively (Fig. 1a, Supplementary Fig. 7, and
Supplementary Data 4). Both IST and IS females displayed
heightened aggression, i.e., increased time spent on keep down,
threat, and offensive grooming (Fig. 1b), as well as spend more
time and engaged more frequently in attacking (Fig. 1c, d)
compared with GH controls (Supplementary Movie 1). We found
a major effect of the estrous cycle on aggression mainly reflected
by lower levels of aggression in IS females in the proestrus or
estrus phase than in the metestrus or diestrus phase (Fig. 1e).
Concerning other behaviors, GH females spent more time dis-
playing non-social behaviors, whereas only IST females showed
increased self-grooming compared with GH females (Fig. 1f).
To further validate our model of enhanced aggression in
females, we treated aggressive IST females with the selective
serotonin reuptake inhibitor (SSRI) escitalopram (10 mg/kg, s.c.),
as SSRIs typically decrease aggression in rodents35. Indeed,
escitalopram significantly reduced the time spent on aggression,
i.e., on keeping down, threatening and attacking, and increased
the latency to attack. Consequently, escitalopram-treated females
displayed more defensive and neutral behaviors (Supplementary
Fig. 1).
The display of high aggression in IST rats is accompanied by
elevated OXT and decreased AVP release in the brain. IST, IS,
and GH rats were either exposed to the FIT or not (control) to
assess the effects of housing conditions as well as an aggressive
encounter on the endogenous OXT and AVP systems (Fig. 1a).
Elevated post-FIT OXT levels were found in the CSF of IST
females compared with GH females (Fig. 2a). In addition, IST and
IS rats exhibited higher levels of OXT in the CSF compared with
their respective non-FIT control groups. Notably, plasma OXT
concentrations did not follow the same pattern (Supplementary
Fig. 2). In contrast to OXT, AVP concentrations in the CSF after
FIT exposure were lower only in IST females without any effect of
housing or training conditions (Fig. 2d). Regarding AVP secre-
tion into the blood, FIT exposure tended to heighten plasma AVP
regardless of housing condition, although the magnitude of this
effect seemed to be reduced in aggressive IST females (Supple-
mentary Fig. 2).
Highly aggressive IST rats had low OXTR and V1aR binding in
the vLS and dLS, respectively. We analyzed OXTR and V1aR
binding in selected brain regions involved in the social/aggressive
behavior network (Supplementary Fig. 2). Among the nine regions
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analyzed, only within the LS OXTRs and V1aRs were affected by
housing and aggression-training conditions. In comparison with
GH rats, IST females exhibited lower OXTR and V1aR binding in
the vLS (Figs. 2b and 2c) and dLS (Figs. 2e and 2f), respectively.
As low glucocorticoid levels have been implicated in the
development of intermale aggression in humans and animals1,8,
we assessed plasma corticosterone concentrations after exposure
to the FIT. Although there was no effect of housing or training
conditions, plasma corticosterone indeed negatively correlated
with aggression in females (Supplementary Fig. 2).
Endogenous OXT promotes, whereas synthetic AVP and OXT
reduces aggression in females. Because of the identified ele-
vated levels of OXT in highly aggressive IST females, we
employed pharmacological and chemogenetic methods to either
increase OXT availability in the brain of low-aggressive, i.e., GH
females, or to block central OXT neurotransmission in the brain
of high-aggressive, i.e., IST females. In addition, to make a parallel
with male studies reporting serenic effects of OXT23, we infused
IST rats with OXT i.c.v. (Fig. 3a).
In detail, intracerebroventricular (i.c.v.) infusion of synthetic
OXT enhanced aggression in GH females (Fig. 3b). Surprisingly,
the same treatment decreased aggression in IST females (Fig. 3c),
and this anti-aggressive effect of OXT was reflected in all
behaviors analyzed (Supplementary Fig. 3). Although these results
might seem puzzling at first glance, the chemical similarity
between OXT and AVP, which co-evolved from a single
nonapeptide36, is known to result in cross-reactivity between
both peptides and each other’s receptors in vitro37 and in vivo,
including in the context of aggression38. To exclude cross-
reactivity of OXT on V1aRs, we blocked either OXTR or V1aR
with selective antagonists (OXTR-A and V1aR-A, i.c.v.)37 10 min
prior to i.c.v. OXT infusion. Whereas the OXTR-A did not
abolish the anti-aggressive effects of OXT, pre-infusion with
V1aR-A did (Fig. 3d and Supplementary Fig. 3), clearly indicating
that the anti-aggressive effect of synthetic OXT in IST females is
mediated via V1aRs.
In order to reveal the involvement of endogenous OXT in
aggression displayed by female rats, we first blocked OXTRs in
IST females and found that i.c.v. infusion of the OXTR-A before
FIT exposure reduced total aggression and threat behavior
(Fig. 3e, Supplementary Fig. 3). Aiming to chemogenetically
stimulate intracerebral OXT release we infected the hypothalamic
paraventricular (PVN) and supraoptic (SON) nuclei of GH
female rats with an rAAV to selectively express GqDREADD
under the control of an OXT promoter fragment (Fig. 3h). The
virus showed a high degree of cell-type efficiency, as 64.37% of
OXT cells in the PVN and 75.1% of OXT cells in the SON were
positive for mCherry, and specificity as 73.9% of mCherry cells in
the PVN and 77.9% in the SON were positive for OXT in
accordance with previous data39. However, a few mCherry-
positive cells outside the PVN (10.8% of total mCherry cells) and
SON (9.3% of total mCherry cells) devoid OXT immunosignals.
Intraperitoneal application of the DREADD ligand clozapine-N-
oxide dihydrochloride increased aggression in diestrus and
metestrus GH females, thereby confirming our pharmacological
results. Intriguingly, estrus and proestrus GH females showed no
increase in aggression. (Fig. 3g and Supplementary Fig. 4).
Finally, as i.c.v. synthetic OXT decreased aggression via
activation of V1aRs, and because low levels of AVP were found












Fig. 1 Social isolation and training reliably enhance aggression in female Wistar rats, independently of the estrous cycle. a Scheme illustrating the
animal groups and experimental timeline. Female Wistar rats were kept either group-housed (GH) or socially isolated (IS). After 5 days of social isolation,
isolated and trained (IST) females were exposed to three consecutive female intruder tests (FIT1 to FIT3), i.e., to aggressive encounters with an unknown
same-sex intruder. Black bars correspond to data from FIT4 (test). Partially drawn using https://biorender.com. b Both IS and IST rats showed increased
total aggression (one-way ANOVA followed by Bonferroni F(2,63)= 16.26, p < 0.0001), keep down (Kruskal–Wallis test followed by Dunn’s H3= 6.69, p=
0.035), threat (H3= 18.98, p < 0.0001) and offensive grooming (H3= 10.8, p= 0.005). c IS and IST females engaged more in attacks (Chi-squared test,
X2= 40.81, p < 0.0001), and d spent a higher percentage of time attacking (H3= 8.8, p= 0.012) than GH females. e IS females in the proestrus and estrus
(Pro-estrus) phase of the estrous cycle displayed less aggressive behavior than metestrus-diestrus (Met-diestrus) females (two-way ANOVA followed by
Bonferroni; factor housing: F(2, 60)= 12.7, p < 0.0001; estrous cycle: F(1, 60)= 8.5, p= 0.005; housing × estrous cycle: F(2, 60)= 1.54, p= 0.22). f IST and IS
females compensated their increased aggression with decreased neutral behaviors (F(2, 63)= 18.76, p < 0.0001), only IST females spent more time self-
grooming (F(2, 63)= 5.79, p= 0.005). All data are shown as mean+SEM. #p < 0.05, ##p < 0.001, ###p < 0.001 vs GH; ep < 0.05 vs met-diestrus. GH: n=
23; IS: n= 21; IST: n= 21.
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would also reduce aggression in IST females. Indeed, the elevation
of AVP availability prior to the FIT resulted in decreased total
aggression, keeping down, threatening behaviors as well as time
spent on attacks (Fig. 3f and Supplementary Fig. 3).
Taken together, these results demonstrate that activation of
OXTRs has a pro-aggressive effect, which is most likely mediated
by endogenous OXT. In contrast, both synthetic OXT and
particularly synthetic AVP showed anti-aggressive effects
mediated via activation of V1aRs.
The pro-aggressive effect of OXT is mediated in the vLS. Based
on the fact that OXTR binding was exclusively reduced in the vLS
of IST females (Fig. 2b), and that the LS is known to regulate
aggression26–28, we hypothesized that the pro-aggressive effect of
endogenous OXT is mediated in the vLS. Thus, we used local
in vivo microdialysis, neuropharmacological and optogenetic
approaches to specifically study the role of the OXT system in the
vLS in aggression displayed by females (Fig. 4a).
In vivo monitoring of OXT release within the vLS revealed an
increased release in IST, but not GH, rats during FIT exposure,
resulting in higher levels of local OXT release observed during the
FIT in IST females compared with GH controls (Fig. 4b,
Supplementary Data 2–3). In order to test for the involvement
of locally released OXT and subsequent OXTR-mediated
signaling in the vLS during aggression in female Wistar rats, we
bilaterally infused an OXTR-A into the vLS of IST rats 10 min
prior to the FIT. Blockade of vLS OXTRs resulted in decreased
total aggression (Fig. 4c), threat and offensive grooming
(Supplementary Fig. 5).
Further evidence for the involvement of septal OXT neuro-
transmission in promoting aggression in female rats was provided
by optogenetic stimulation of oxytocinergic axons in the vLS of
GH rats. To this end, GH rats were infected with a
channelrhodopsin (ChR2) rAAV in the PVN and SON, which
is expressed under the control of an OXT promoter fragment
(Fig. 4d). Similarly to the GqDREADD rAAV, the ChR2 rAAV
showed a high degree of cell-type efficiency, as 64.43% of
OXT cells in the PVN and 75.5% of OXT cells in the SON were
positive for mCherry; and cell-type specificity, as 74.4% of the
mCherry cells in the PVN and 76.99% of mCherry cells in the
SON were positive for OXT. The specificity of the virus for
targeting OXT neurons has been proven before40, although in the
present experiment a limited number of mCherry-positive cells
outside the PVN (10.4% of total mCherry cells) and SON (11.7%
of total mCherry cells) devoid OXT immunosignals.
In agreement with the pro-aggressive effects of endogenous
OXT (Figs. 2 and 3), blue-light stimulation of vLS OXT axons
during the FIT increased the level of aggression in a time- and
estrous cycle-dependent manner (see Fig. 4e–g). Cumulative
analyses showed a main effect of the viral infection, i.e., only
metestrus/diestrus, but not proestrus/estrus, females that
expressed ChR2 and received blue-light stimulation exhibited







Fig. 2 The high levels of aggression displayed by isolated and trained (IST) rats are accompanied by high OXT and low AVP concentrations in
cerebrospinal fluid (CSF), and low OXT and V1a receptor binding in the lateral septum (LS). a IS and IST females showed higher concentrations of OXT
in CSF immediately after exposure to the female intruder test (FIT) compared with respective control rats (CTRL) (two-way ANOVA followed by
Bonferroni: factor FIT: F(1,44)= 3.91, p= 0.054; housing: F(2,44)= 1.96, p= 0.152; FIT × housing: F(2,44)= 4.68, p= 0.014). b IST females presented
decreased OXT receptor (OXTR) binding, displayed as relative optical density (ROD), in the ventral portion of the LS (vLS) (Kruskal–Wallis test followed by
Dunn’s: H(3)= 7.12, p= 0.02. c Scheme illustrating localization of OXTR in the vLS, and magnification of representative example autoradiograph (left: GH;
right: IST). d FIT exposure decreased CSF AVP levels only in IST rats (two-way ANOVA, factor FIT: F(1,50)= 15.98, p= 0.0002; housing: F(2,50)= 2.13, p=
0.129; FIT × housing: F(2,50)= 0.90, p= 0.41). e IST females presented decreased V1aR binding, shown as ROD, in the dorsal part of the LS (dLS) (H(3)=
8.72, p= 0.006). f Scheme illustrating localization of V1aR in the dLS and magnification of representative autoradiograph (left: GH, right: IST). All data are
presented as mean+SEM. #p < 0.05, ##p < 0.01 vs GH; *p < 0.05, **p < 0.01 vs control. Binding: GH: n= 8; IS: n= 4; IST: n= 5; OXT: GH: n= 17; IS: n= 16;
IST: n= 17; AVP: GH: n= 18; IS: n= 20; IST: n= 18.
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movie 2 and 3, and Supplementary Fig. 4). Surprisingly, the
second light stimulation failed to enhance aggression displayed by
GH rats, and this could be owing to a depletion of presynaptic
OXT or non-selective binding of OXT to V1aRs. Future studies
should focus on unraveling these hypotheses.
AVP exerts an anti-aggressive effect within the dLS. To localize
the anti-aggressive effects of AVP identified above, we used
intracerebral microdialysis and neuropharmacology within the
dLS (Fig. 5a), as local V1aR binding was decreased in highly
aggressive IST females (Fig. 2e).
AVP release was monitored within the dLS of GH and IST rats
under basal conditions and during exposure to the FIT. Whereas
in GH rats, AVP release was found to significantly increase to
130%, such a rise was not found in IST females resulting in lower
AVP levels during the FIT compared with GH controls (Fig. 5b,
Supplementary Data 2–3). Next, to prove that AVP acts on V1aRs
specifically in the dLS to inhibit aggression, we infused AVP,
TGOT (a selective OXTR agonist), or OXT either into the dLS,
where we identified predominantly V1aRs, or into the vLS, where
predominantly OXTRs were found (Fig. 2c and f). Only bilateral
infusions of AVP, into the dLS of IST rats resulted in decreased
total aggression, keep down, and offensive grooming (Fig. 5c and
Supplementary Fig. 5). In contrast, none of the treatments in the
vLS affected aggression (Fig. 5d and Supplementary Data 2).
Surprisingly, V1aR-A administration enhanced aggression in
both GH and IST rats (Fig. 5e–f and Supplementary Fig. 5),
confirming the anti-aggressive effect of endogenous AVP,
independent of the housing condition.
Spontaneous activity in neurons in the dLS and vLS is differ-
entially modulated by activation of OXTRs and V1aRs. The LS
consists mostly of GABAergic neurons grouped into different
subnuclei according to the expression of different neuropeptides
and receptors, most importantly V1aRs and OXTRs34,41. It has
been reported that spontaneous activity in these neurons is
modulated by AVP in multiple ways42. In our behavioral para-
digm, activation of OXTRs in the vLS enhanced, whereas acti-
vation of V1aRs in the dLS rather reduced aggression in female
rats. To test whether such subregion- and neuropeptide-specific
effects can also be observed at the level of network activity, we
recorded spontaneous activity of GABAergic dLS and vLS neu-
rons in brain slices from female juvenile (20–25 days old) Venus-
VGAT rats (whole-cell voltage-clamp at −60 mV, biocytin-
labeling), and investigated OXTR- and V1aR-mediated effects by
applying either TGOT (1 µM) or a combination of OXTR-A (10
µM) and AVP (1 µM) to the bath. We also characterized these
two neuronal populations with respect to morphological and
molecular parameters (Fig. 6a).
Neurons in the dLS exhibited a higher morphological
complexity compared with vLS neurons (Fig. 6a–f), as indicated

































































Fig. 3 Endogenous OXT promotes, whereas synthetic AVP and OXT reduce aggression in females. a Experimental design for pharmacological and
chemogenetic experiments targeting the OXT and AVP systems in isolated and trained (IST) and group-housed (GH) rats. (AAV adeno-associated
DREADD virus infusion into the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei; AVP arginine vasopressin; arrow=drug infusions;
FIT female intruder test, IS social isolation, OXT oxytocin, OXTR-A OXT receptor antagonist, SURG surgery, V1aR-A V1a receptor antagonist,WO wash-out).
b i.c.v. infusion of OXT (50 ng/5 µl) increased aggression in GH (two-tailed Student’s t test t(19)= 2.46, p= 0.024), c but decreased aggression in IST
females (t(8)= 2.33, p= 0.048, data corresponds to FIT4 and 6). d i.c.v. infusion of V1aR-A (750 ng/5 µl), but not OXTR-A (750 ng/5 µl), blocked the
anti-aggressive effects of OXT in IST females (one-way ANOVA followed by Bonferroni F(3,28)= 10.1, p= 0.001). Also, the V1aR-A alone did not
affect aggression. Both, e i.c.v. infusion of OXTR-A (t(28)= 4.96, p < 0.0001) and f i.c.v. AVP (0.1 or 1 ng/5 µl) reduced total aggressive behavior (F(3,54)=
7.48, p= 0.0003) in IST rats. g Chemogenetic activation of OXT neurons in the PVN and SON increased aggression only in metestrus-diestrus GH rats
(two-way ANOVA, factor treatment: F(1,19)= 3.342, p= 0.083; estrous cycle: F(1,19)= 6.68, p= 0.018; treatment × estrous cycle: F(1,19)= 6.45, p= 0.02).
h Confirmation of virus infection in the PVN (right) and SON (left). OXT-neurophysin I staining: green; mCherry (virus): red. Scale bars 300 µm. Data
are shown as mean+SEM. *p < 0.05; **p < 0.01; ***p < 0.0001 vs either vehicle or control; ep < 0.05 vs met-diestrus. OXT: GH: n= 9 and 12; IST: n= 9;
AVP: n= 18, 9, and 9, respectively; OXTR-A: n= 14 and 15; combination OXT/OXTR-A/V1aR-A: n= 8, 6, 8, 9, and 7, respectively; chemogenetics: n= 6
and 15. Control group consisted of (i) rAAV1/2 OXTpr-mCherry+CNO, no virus infusion + (ii) saline, or (iii) CNO.
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Fig. 4 The pro-aggressive effect of OXT is mediated in the vLS. a Scheme illustrating the experimental design for pharmacological, microdialysis, and
optogenetic experiments targeting the OXT system (AAV adeno-associated virus microinfusion into the hypothalamic paraventricular (PVN) and
supraoptic (SON) nuclei; arrow=drug infusions; FIT female intruder test; GH group-housed; IS social isolation; IST isolated and trained, MD microdialysis,
SURG surgery, OXT oxytocin, OXTR-A OXT receptor antagonist, vLS ventral part of the lateral septum). b IST, but not GH females showed an increased rise
in the percentage of OXT release (OXT content in microdialysates sampled during the FIT/OXT content in microdialysates sampled in the baseline × 100)
in the vLS during the FIT (one sample Student’s t test IST: t(7)= 2.65, p= 0.033; GH: t(7)= 0.83, p= 0.43), thus OXT release during FIT tended to be
higher in IST compared with GH rats (t(14)= 2.12, p= 0.053). Insert shows that absolute OXT content in microdialysates sampled under basal conditions
did not differ between the groups (t(14)= 0.54, p= 0.60). c OXTR-A (100 ng/0.5 µl) infusion into the vLS reduced total aggression (two-tailed Student’s t
test t(26)= 2.58, p= 0.016) in IST females. d–g Optogenetic stimulation (indicated by blue columns) of OXT axons in the vLS of GH females during the FIT.
d Confirmation of virus infection in OXT neurons of the PVN (left) and SON (right). OXT-neurophysin I staining: green; mCherry (virus): red. Scale bars
300 µm. Blue-light stimulation of channelrhodopsin (ChR2)-OXT fibers enhanced aggressive behavior in e metestrus-diestrus (Met-diestrus) (two-way
ANOVA followed by Bonferroni factor: time: F(5,75)= 2.72, p= 0.026; virus: F(5,75)= 20.03, p= 0.0004; time × virus: F(5,75)= 1.056, p= 0.392), but
not in f proestrus-estrus (Pro-estrus) females (time: F(5,70)= 2.84, p= 0.02; factor virus: F(1,14)= 2.73, p= 0.12; virus × time: F(5,70)= 0.02, p= 0.97).
g Cumulative analyses show that light stimulation enhanced aggression only in ChR2-OXT females in the metestrus-diestrus phase of the cycle (factor
virus: F(1,15)= 13.06, p= 0.0026; estrous cycle: F(1,15)= 2.07, p= 0.17; virus × estrous cycle: F(1,15)= 1.114, p= 0.31). Data are shown as mean+SEM. (#)p=
0.05 vs GH; *p < 0.05, **p < 0.01 vs either vehicle, baseline or ChR2 control; +p < 0.05 vs 0–2 time point. Microdialysis: n= 8; OXTR-A: n= 13 and 15;
optogenetics: n= 8 and 9. Control group consisted of rAAV1/2 OXTpr-mCherry + light stimulation.
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(Fig. 6i). Apart from the specific expression of V1aRs and OXTRs,
dorsal and vLS neurons also differed regarding the expression
of other markers: somatostatin-positive cell bodies were only
found in the dLS (Fig. 6g), whereas estrogen receptor α (ERα)
expressing cells were exclusively located in the vLS (Fig. 6h),
further reinforcing that vLS and the dLS neurons are distinct
populations.
Although excitatory spontaneous activity was not observed
under our recording conditions, in line with previous
observations42, selective activation of OXTRs in the vLS
differentially affected the spontaneous inhibitory activity in dLS
versus vLS (Fig. 6j and l). In the dLS cells, the selective OXTR
agonist TGOT caused an increased frequency of spontaneous
IPSCs (sIPSCs). sIPSCs were entirely blocked by further addition
of bicuculline (50 µM, selective GABA-A antagonist) (Fig. 6j–k),
which confirmed the exclusive GABAergic origin of these
currents. In agreement with those results, blockade of OXTRs
by selective OXTR-A in the dLS decreased sIPSC frequency
(Supplementary Fig. 6). Conversely, in the vLS neurons
responded to TGOT with a decreased sIPSC frequency (Fig. 6l–m)
indicating a reduced inhibitory tone following OXTR activation.
Again, sIPSCs were entirely blocked by bicuculline.
V1aR activation increased sIPSC frequency specifically in the
dLS neurons, whereas no consistent effect was seen in vLS cells
(Supplementary Fig. 6).
Altogether, our data demonstrate that activation of OXTRs in
the vLS concomitantly weakens the tonic inhibition of vLS
GABAergic neurons and strengthens tonic inhibition of dLS
GABAergic neurons. We also could confirm subregion-specific
effects of AVP, as only dLS neurons were affected by V1aR
activation, in line with behavioral experiments where AVP effects
were also observed only in the dLS. In addition, dLS neurons
showed extended dendritic arborizations and other cell markers
than vLS neurons.
An intrinsic GABAergic circuit within the LS regulates
aggression in female Wistar rats. After we have shown that (i)
activation of vLS OXTR increases, whereas dLS V1aR decreases
aggression, and (ii) spontaneous inhibition is increased in dorsal
and decreased in ventral cells by OXTR activation, we hypothe-
sized that those subregions would also be differentially activated
after an aggressive encounter. Therefore, we compared the neu-
ronal activity within the vLS and dLS of Venus-VGAT GH and
Fig. 5 AVP exerts anti-aggressive effects within the dLS. a Scheme illustrating the experimental design for pharmacology and microdialysis experiments
targeting the AVP system (AVP arginine vasopressin, arrow=drug infusions, FIT female intruder test, GH group-housed, IS social isolation, IST isolated and
trained; MD microdialysis, SURG surgery, dLS dorsal part of the lateral septum, OXT oxytocin, TGOT [Thr4,Gly]OXT, OXT receptor agonist, vLS ventral part
of the lateral septum; V1aR-A V1aR receptor antagonist). b GH, but not IST females showed an increased rise in the percentage of AVP release (AVP
content in microdialysates sampled during the FIT/AVP content in microdialysates sampled in the baseline × 100) in the dLS during the FIT (Wilcoxon
signed-rank test GH: W(9)= 45, p= 0.0039; IST: W(7)=−4.00, p= 0.81), thus AVP release during the FIT was higher in GH than in IST rats
(Mann–Whitney U test= 6.00, p= 0.0052). Insert shows that absolute AVP content in microdialysates sampled under basal conditions did not differ
between the groups. c Infusion of AVP, but not OXT or TGOT (all at 0.1 ng/0.5 µl), into the dLS decreased total aggression in IST females (F(3,30)= 7.292,
p= 0.0008). d AVP infusion into the vLS did not change aggression in IST females (F(3,25)= 0.11, p= 0.95). Local blockade of V1aR (100 ng/0.5 µl) prior
to the FIT increased aggression in e GH (two-tailed Student’s t test t(13)= 3.31, p= 0.006) and f IST rats (t(20)= 2.14, p= 0.045). Data are shown as mean
+SEM. #p < 0.05 vs GH; *p < 0.05, **p < 0.01 vs either vehicle or baseline. Microdialysis: n= 8 and 9; AVP, OXT, TGOT dLS: 12, 5, 5 and 12, respectively;
vLS: 8, 8,7 and 6, respectively; V1aR-A: GH: n= 8 and 7, IST: n= 12 and 11.
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IST rats after exposure to the FIT using pERK as a neuronal
activity marker12,14,15.
We found striking regional differences in neuronal activity in
the LS of highly aggressive IST females compared with low-
aggressive GH rats (Fig. 7a–d). In detail, in the dLS FIT exposure
and the display of high aggression by IST rats resulted in a
decreased total number of both pERK-positive and VGAT/pERK-
positive cells (Fig. 7a–b and e), with a negative correlation found
between the amount of double-labeled cells in the dLS and
aggression (Fig. 7f). In contrast, in the vLS of IST females, we
found a trend towards more pERK-positive cells and an increased
number of VGAT/pERK-positive cells (Fig. 7c–d and g), which
did not correlate with aggression (Fig. 7h and Supplementary
Data 2–3).
To further confirm the dLS as an anti-aggressive center versus
the vLS as a pro-aggressive center, and consequently to create a
causal link between neuronal activity and behavior, we infused
rats with a selective GABA-A agonist muscimol 10 min before the
FIT. As predicted, inactivation of the dLS in GH rats enhanced
aggression, threat behavior and the percentage of rats showing
attacks (Fig. 7i–j and Supplementary Data 2–3). In contrast,
opposing effects were seen in the vLS of IST rats, where muscimol
decreased aggression and the percentage of rats showing attacks.
(Fig. 7k–l and Supplementary Data 2–3).
Fig. 6 Spontaneous activity in neurons of the dLS and vLS is differentially modulated by activation of OXTRs. a Scheme indicating the receptor binding-
specific delimitation of the vLS (OXTR) and dLS (V1aR) used during voltage-clamp experiments, including two representative dLS and vLS cells. b Maximal
z-projection of biocytin-filled vLS cell (streptavidin-CF633) overlaid with a single z-plane of VGAT and DAPI. c Magnification of cell body from the cell
shown in b. d Neurite reconstruction of cell shown in b, and e of the cell shown in f; the gray-dotted line indicates the border of the lateral ventricle (LV).
f Maximal z-projection of a biocytin-filled dLS (streptavidin-CF633) cell overlaid with a single z-plane of VGAT and DAPI. g Magnification of a single z-
plane indicating the presence of somatostatin (SOM) cell bodies (arrowheads) only in the dLS. h Magnification of a single z-plane indicating the presence
of ERα-positive cell bodies (arrows) only in the vLS. i Morphological characterization of LS neurons. dLS cells exhibited more neurite branches (two-tailed
Student’s t test t(4)= 4.84, p= 0.0072) and branching points (t(4)= 4.85, p= 0.0072) longer neurite length (t(4)= 4.80, p= 0.0078), and wider soma
areas (Mann–Whitney U test U= 1.0, p= 0.016) than vLS cells. Representative spontaneous current traces during TGOT (1 µM) and bicuculline (50 µM)
bath application in dLS j and vLS l cells. k TGOT increased sIPSC frequencies in dLS cells (Wilcoxon signed-rank test W(9)= 55, p= 0.002) and
m decreased sIPSC frequencies in vLS cells (W(7)=−36, p= 0.0078). TGOT had no effect whatsoever on the sIPSC amplitude independent of the
subregion. Data are shown as mean+SEM. *p < 0.05, **p < 0.01, vs either dLS or aCSF. Morphology: n= 5; electrophysiology: dLS n= 10, vLS n= 8.
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Discussion
Aiming to study neural mechanisms of aggression in virgin
female rats, we have established a behavioral paradigm combining
social isolation and aggression-training by repeated exposure to
the FIT, which reliably exacerbated the mild levels of aggression
typically displayed by GH female Wistar rats. In addition, we
have shown that female aggression is controlled by a fine-tuned
balance between OXT, AVP, and GABA neurotransmission
within two distinct neuronal populations of the LS, i.e., the dLS
and vLS, with contrasting subregional effects of OXT and AVP
(Fig. 8). In detail, the display of high aggression by IST females
during the FIT was accompanied by elevated OXT release within
the vLS, which was also reflected by higher OXT levels in their
CSF. This indicates the involvement of septal OXT in the high
aggression displayed by IST rats, which we further confirmed by
complementary pharmacological, chemogenetic and optogenetic
approaches: (i) Pharmacological blockade of OXTR either i.c.v. or
locally in the vLS attenuated aggression in IST rats, whereas (ii)
chemogenetic and optogenetic stimulation of OXT neurons in the
PVN and SON, and of OXT axons projecting to the vLS,
respectively, heightened the aggression of low-aggressive and
non-receptive GH females.
Concerning the involvement of the brain AVP system in
female aggression, we revealed a completely different picture.
Highly aggressive IST females showed unchanged AVP release
within the dLS during an aggressive encounter, which was also
reflected by lower AVP content in the CSF. As further proof of an
inhibitory effect of AVP on female aggression, infusion of AVP
Fig. 7 An intrinsic GABAergic circuit within the subregions of the LS regulates aggression in female Wistar rats. a–d Example average z-projects
showing pERK (Alexa594) immunostaining in Venus-VGAT females after exposure to the female intruder test (FIT). a dorsal LS (dLS) of a group-housed
(GH), i.e., low-aggressive female, b dLS of an isolated and trained (IST), i.e., high-aggressive female, c ventral LS (vLS) of a GH female, d vLS of an IST
female (LV lateral ventricle, VGAT vesicular GABA transporter). e–h Neuronal activity in the LS reflected by pERK staining after FIT exposure: e In the dLS of
IST females less pERK-positive cells (two-tailed Student’s t test t(9)= 4.20, p= 0.0023) and fewer pERK/VGAT co-localized cells were found (t(9)= 3.75,
p= 0.004). f Aggression negatively correlated with the number of pERK/VGAT-positive cells in the dLS (Pearson’s correlation r=−0.746, p= 0.008).
g In the vLS of IST females a tendency of more pERK-positive cells (t(9)= 2.07, p= 0.068) and a higher number of pERK/VGAT-positive cells was found
(T(9)= 2.28, p= 0.049). h Aggression did not correlate with the number of pERK/VGAT-positive cells in the vLS (r= 0.4915, p= 0.1247). i Infusion of
muscimol (10 ng/0.5 µl) into the dLS increased total aggression (t(12)= 2.52, p= 0.027) and threat (Mann–Whitney U test U= 5.00, p= 0.011) in GH
rats. j Inhibition of the dLS also enhanced the percentage of rats showing attacks (Fisher exact test, p < 0.0001). k Muscimol in the vLS decreased total
aggression (t(13)= 3.191, p= 0.0071) and tended to decrease threat behavior (t(13)= 1.832, p= 0.090). l Inhibition of the vLS also reduced the percentage
of rats showing attacks (p < 0.0001). Data are shown as mean+SEM. #p < 0.05, ##p < 0.01 vs GH; *p < 0.05, **p < 0.01, ***p < 0.0001 vs vehicle. Neural
activity: GH n= 6 and IST n= 5; muscimol: dLS: n= 7 vLS: n= 8 and 7.
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either i.c.v. or directly into the dLS reduced the aggression seen in
IST rats, whereas blockade of V1aR in the dLS exacerbated
aggression in both GH and IST rats.
OXT and AVP have been repeatedly described as important
neuromodulators of social behaviors in rodents, acting either
synergistically or antagonistically depending on the social context
and sex8,9,22,24,36,43. In males, reduced aggression has been
reported in rats after i.c.v. infusion with synthetic OXT23 and in
mice after optogenetic stimulation of hypothalamic OXT
neurons43. In contrast, the few studies on OXT-effects on female
aggression rather revealed pro-aggressive or antisocial effects, for
example, in female rhesus monkeys44, non-lactating women8,45,
and in lactating female rats18,33. Although the factors motivating
the display of aggression and its severity likely differ in lactating
versus virgin females5,33,46,47, we should highlight that, from an
evolutionary point of view, co-opting the same neuropeptidergic
systems for promoting aggression in lactating females to protect
the offspring, and in virgin females to protect their territory or to
get access to resources, makes sense, as high activity of the brain
OXT system reflected by elevated neuropeptide synthesis, release
and receptor binding18,24,33,36 is known to underlie maternal
aggression24,33,36,48. Further evidence for a sex-specific effect of
OXT on social behavior comes from studies on social motivation,
where OXT is essential for naturally occurring social preference
behavior in male rats and mice49, but not in virgin female rats50.
Thus, our results on a pro-aggressive effect of OXT in virgin
females add an important piece of evidence to the sex-specific
effects of OXT on social behaviors.
In our experiments, aggression in females was found to be
dependent upon the estrous cycle. Indeed, a previous study has
shown low aggression in estrus rats51, as we have seen in the IS
proestrus/estrus females. In addition, chemo- and optogenetic
stimulation of the OXT system either centrally or in the vLS
elevated aggression levels exclusively in metestrus/diestrus GH
rats. In this context, it is of note that OXTR expression and
binding in regions involved in the regulation of aggression, such
as the VMH, bed nucleus of stria terminalis (BNST), and LS,
undergo dynamic changes during the estrous cycle in a sex
steroid-dependent manner36,52. Furthermore, sex steroids affect
OXT expression and release as shown in vitro53 and in vivo54.
Although one could hypothesize that activation of local ERα in
the vLS is counteracting the effects of OXT in females, the extent
of how the estrous cycle is involved in the modulation of the vLS
neurons and, consequently, on local OXT and AVP actions on
female aggression remains to be studied.
Furthermore, we found a mismatch between OXT release and
OXTR binding in the LS, i.e., high local OXT release was found in
rats with reduced OXTR binding. Although this might seem
confusing at first sight, similar mismatches between release and
receptor binding patterns have been described before in asso-
ciation with increased OXT availability in male mice after fear-
conditioning36.
Although several pieces of evidence support pro-aggressive
effects of AVP in males9,22,55,56, conflicting data supporting an
anti-aggressive effect of AVP have been described in animal
models of high and abnormal aggression. For example, male rats
bred for low anxiety and characterized by excessive and abnormal
aggression31 show low levels of AVP release in the LS during the
resident-intruder test21. Also, aggressive male mice with a short
attack latency exhibit decreased AVP innervation of the LS57,
thereby demonstrating not only an association between abnormal
and high aggression, but furthermore a blunted activity of the
septal AVP system. In agreement, high aggression displayed by
dominant males has also been linked to reduced septal AVP
signaling, i.e., alpha male mice showed decreased V1aR binding
in the LS, when compared with subordinate males32, and syn-
thetic AVP was able to flatten dominant behavior in rhesus
macaques58. In lactating females, the link between AVP and
aggression seems to be complex as well. Whereas synthetic or
endogenous AVP has been shown to decrease maternal aggres-
sion in Sprague-Dawley rats19,20, contrasting and probably
anxiety-dependent effects have been described in the central
amygdala of high anxiety Wistar rats, where AVP release was
associated with maternal aggression17. Accordingly to our data,
serenic effects of AVP have also been shown in non-lactating
hamsters9,59 and rhesus macaques44. Interestingly, recent studies
in humans have highlighted the pro-social role of AVP as a
potential treatment for social dysfunctions, since intranasal AVP
was able to increase risky cooperative behavior in men60 and to
enhance social skills in autistic children61.
After identification of the specific pro-aggressive effect of OXT
in the vLS, and anti-aggressive effect of AVP in the dLS, of virgin
female Wistar rats (Fig. 8), in the final set of experiments we were
able to link these neuropeptidergic actions with specific regional
effects in neuronal activity after an aggressive encounter. In detail,
elevated pERK expression reflecting high neuronal activity was
found in the vLS of highly aggressive IST females, whereas pERK
expression was elevated in the dLS of low-aggressive GH rats.
These findings were functionally validated by manipulation of
local GABAergic neurotransmission using local muscimol infu-
sions, demonstrating that dLS neurons inhibit, whereas vLS
neurons seem to promote aggression in females. Subnetwork-
dependent responses were also seen after OXTR and V1aR acti-
vation in vitro. TGOT decreased the inhibitory spontaneous
Fig. 8 The balance between OXT and AVP regulates the inhibitory tonus
within the LS in order to control aggression in female rats. The scheme
depicts the main findings of this manuscript. Furthermore, it hypothesizes
that subtle alterations in OXT and AVP release within the LS may impact
GABAergic neurotransmission to generate aggressive behavior in female
rats. On the left side is depicted, how the brain of a GH female responds to
an intruder: a combination of low OXT release ventrally and high AVP
release dorsally evokes an increased activity of the dLS, thereby reducing
aggression. On the right side is depicted, how the brain of an IST female
responds to an intruder: a combination of high OXT release ventrally and
low AVP release dorsally culminates in increased tonic inhibition of dLS
(dotted line indicates hypothetical pathway) and increased activation of the
vLS, promoting aggression. Dorsal and ventral neurons are shown in
proportion to their real size. AVP arginine vasopressin, ERα estrogen
receptor α, IPSC inhibitory post-synaptic current, LV lateral ventricle, MS
medial septum, OXT oxytocin, OXTR oxytocin receptor, SOM somatostatin,
V1aR V1a receptor. Drawn using https://biorender.com.
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activity ventrally, whereas it increased it dorsally. Thus activation
of OXTRs located exclusively in the vLS leads to enhanced
GABAergic inhibition of GABAergic neurons in the dLS, possibly
facilitating aggression. In addition, AVP increased sIPSCs fre-
quency dorsally, but did not affect sIPSCs ventrally. This obser-
vation refines the results from an earlier study42 showing that
V1aR activation indirectly enhances the inhibitory neuro-
transmission of a majority of LS neurons, notwithstanding the
dorso-ventral localization of the recorded cells. Thus, according
to our results, both anti-aggressive and synaptic effects of AVP
appear to be mediated exclusively within the dLS.
The role of the LS in suppressing aggression has been described
for decades10,25–30. However, only one recent paper has shown
the existence of local microcircuits within the LS regulating
aggression in male mice56. Supporting the pro-aggressive role of
AVP in males9,22,24,55, V1b receptor activation on presynaptic
terminals of hippocampal fibers to the LS increased aggression via
stimulation of inhibitory interneurons in the dLS projecting to the
vLS. Although this data contrasts with ours, we have to keep in
mind that the regulation of aggression within the LS, via OXTRs
and V1aRs, might be underlined by sex- and species-dependent
mechanisms, as both males and females34, as well as mice and
rats32,34, differ in their receptor binding. In addition, we inves-
tigated the role of V1aRs, but not V1bRs and differential effects
on aggression are likely, also the involvement of endogenous
AVP acting on V1bRs has not been shown in the previous
study56. Based on our finding that V1aR activation increases
sIPSCs frequency exclusively in the dLS, we could hypothesize
that V1aR activation might overrule V1bR effects by inhibiting
V1bR-responsive interneurons, thereby decreasing aggression.
Accordingly, in our model of female aggression, activation of
V1aRs in the dLS seems to overshadow any possible pro-
aggressive V1bR-mediated action, since AVP administration in
the dLS was able to mimic the anti-aggressive effects of i.c.v. AVP
in IST females. Indeed, AVP has been shown to present a higher
affinity to V1aRs over V1bRs in vitro37. Nevertheless, future
studies should address how the interplay between V1aR and
V1bR activation within the dLS affects aggression in females.
Supporting our findings, a neurocircuit involving contrasting
effects of OXTR and V1aR activation has been described in the
context of fear in the central amygdala, wherein activation of
putative OXTR-positive cells led to inhibition of V1aR-positive
cells via GABAergic transmission, which abolished fear-related
behavioral effects of V1aR activation40,62. To the best of our
knowledge, such a mechanism has never been described before in
the context of aggression. In further support of our finding that
high levels of OXT in the vLS leads to increased tonic inhibition
of the dLS via GABAergic projections, neural projections from
the vLS towards the dLS have also been described in male Wistar
rats63. In addition, blockade of GABA-A receptors in the dLS of
lactating mice reduced maternal aggression30. Thus, aggression in
animals with a higher OXT system activity33,36 is at least partially
modulated by increased GABA neurotransmission in the dLS.
Although our data depict compelling evidence that OXT release
in the vLS facilitates aggression via increasing tonic inhibition
onto dLS neurons, whether those phenomena are functionally
associated remains to be determined in further studies.
Taken together, our results shed light on the neurobiological
mechanisms underlying aggression in females. We have shown
that the level of aggression expressed by virgin female Wistar rats
is determined by a fine-tuned balance between OXT- and AVP-
mediated neuromodulation in septal sub-networks. Disturbances
in this balance, such as a shift towards a more dominant OXT or
AVP neurotransmission, lead to distinct aggression responses.
Dorsal V1aR-expressing neurons of the LS seem to be pivotal for
the AVP-induced inhibition of female aggression, whereas ventral
neurons in the OXTR-expressing LS appear to be the main
generators of OXT-induced aggression. In addition, we propose a
hypothetical mechanism by which activation of OXTRs reduces
tonic inhibition of vLS neurons, which in turn may enhance their
GABA transmission onto the dorsal cells and thus ultimately may
reduce septal gating on aggression (Fig. 8).
Methods
Ratlines and animal care. Adult virgin female Wistar rats (10–14 weeks old) bred
in the animal facilities of the University of Regensburg (Germany) were used for
behavioral experiments. Intruders, female Wistar rats were obtained from Charles
Rivers Laboratories (Sulzfeld, Germany) and kept in groups of 3–5 animals in a
separate animal room. All rats were kept under controlled laboratory conditions
(12:12 h light/dark cycle; lights off at 11:00, 21 ± 1 °C, 60 ± 5% humidity) with
access to standard rat nutrition (RM/H, Sniff Spezialdiäten GmbH, Soest, Ger-
many) and water ad libitum. For patch-clamp (p20–25) and pERK immunohis-
tochemistry analyses (10–14 weeks), female Venus-VGAT rats (VGAT, vesicular
GABA transporter; lineVenus-B, W-Tg(Slc32a1-YFP*)1Yyan, Wistar
background)64 that were bred in the animal facilities of the University of
Regensburg were used. All procedures were conducted following the Guidelines for
the Care and Use of Laboratory Animals of the Local Government of Oberpfalz
and Unterfranken.
Female intruder test. The FIT was performed in the early dark phase (between
12:00 and 16:00) under dim red light conditions. An unfamiliar female intruder
weighing between 10 and 20% less than the resident12 was released into the home
cage of the resident for 10 min. The test was videotaped for later analysis by an
experienced observer blind to treatment using JWatcher event recorder Program65.
The percentage of time the resident spent with four main behavioral aspects was
scored: (i) aggressive behaviors, i.e., keep down (standing over the intruder and
keeping it against the substrate, piloerection is often present), threat behavior
(moving towards the opponent, chasing or pushing it away, piloerection is often
present), offensive grooming (nibbling, pulling, and biting the fur on the neck and
back of the intruder), and attacks (attack bites on the neck, back or flanks of the
intruder, predicted by clinch behavior); (ii) neutral behaviors, i.e., exploring and
investigating the home cage, drinking, eating and self-grooming; (iii) social beha-
viors, i.e., non-aggressive social interactions, sniffing, following; and (iv) defensive
behavior, i.e., submissive posture, kicking a pursuing intruder with hind limb. We
also monitored sexual behavior (lordosis, hopping, darting and mounting) and
immobility. In addition, we scored the frequency of attacks as well as the latency to
the first attack. Residents had vaginal smears taken after the FIT to verify
the estrous cycle; all phases of the estrous cycle were included in the study (for
detailed behavioral analyses of all experiments please see Supplementary Data 2–3
and 6). The intruder’s cycle was not tracked during the study.
Overview of the in vivo experiments
Animal groups for OXT/AVP measurements in CSF, plasma, and receptor auto-
radiographic analyses (Fig. 1a). Female Wistar rats were split into three different
housing conditions: GH females were kept in groups of three to five animals per
cage, IS females were singly housed for 8 days, and IST females were also kept
singly for 8 days, but from day 5 on, they underwent three consecutive FITs for
aggression-training. On day 9, GH females were singly housed 4 h prior to the
behavioral experiments. One hour after lights went off, GH, IS, and IST rats were
either exposed to the FIT, whereas control rats were left undisturbed in their home
cage (behavioral data displayed in Fig. 1). Immediately after the FIT, rats were
deeply anesthetized using intraperitoneal (i.p.) urethane (25%, 1.2 ml/kg) to allow
CSF collection via puncture of the Cisterna cerebromedullaris. After decapitation,
brain and trunk blood were collected for receptor binding and hormonal mea-
surements, respectively (data displayed in Fig. 2). For radioimmunoassays, animals
were again split into two groups according to the peptide measured, i.e., half of the
subjects were used for OXT radioimmunoassay (RIA), whereas the other half was
used for AVP RIA. Here we again counterbalanced levels of aggressin to avoid
uneven groups. In addition, samples coming from rats that either we could not
extract or had shown blood in their CSF were not included in the assays.
Neuropharmacology design. For pharmacological experiments, female rats were
split into GH and IST conditions. All females underwent surgery for i.c.v. or local
cannula implantation. IST females were left undisturbed for recovery for 3 (i.c.v.)
or 5 (local) days. The aggression training was performed as described above, except
for the fact that residents received a sham-infusion before the FIT to get used either
to the i.c.v. or local infusion procedure. GH animals were kept single-housed
overnight for recovery and brought back to their original groups the next day until
the start of the experiments when they were transferred into an observation cage
and single-housed for 4 h before the FIT. All animals were handled daily to get
used to the infusion procedure. Typically, a cross-over, within-subjects design was
used for all i.c.v. agonist experiments, whereas a between-subjects design was used
for the local infusions and i.c.v. antagonists experiments. Additionally, to guarantee
that all groups had similar average levels of aggression before pharmacological
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manipulations, we allocated IST rats into the treatment groups according to their
average levels of aggression expressed in the third session of training.
Microdialysis. OXT and AVP release within the LS was monitored in GH and IST
females before and during FIT exposure. After 4 days of training, IST rats had their
microdialysis probes implanted into the LS. After 1 day of recovery, IST subjects
received the 5th training FIT to confirm their previous levels of aggression. On the
following day, both GH and IST animals underwent the microdialysis procedure.
In brief, rats were connected to a syringe mounted onto a microinfusion pump via
polyethylene tubing and were perfused with sterile Ringer’s solution (3.3 μl/min,
pH 7.4) for 2 h before sampling of microdialysates to establish an equilibrium
between inside and outside of the microdialysis membrane. One hour after lights
went off, three consecutive 30-min dialysates were collected (baseline samples 1
and 2 represented in Figs. 4 and 5 as an average of both time-points) and during an
ongoing FIT (sample 3). Dialysates were collected into Eppendorf tubes containing
10 μl of 0.1 M HCl, were immediately frozen on dry ice, and stored at −20 °C until
subsequent quantification of AVP and OXT by radioimmunoassay (for behavioral
analyses see Supplementary Data 2–3). Microdialysis data are displayed here as a
percentage of release from baseline (Peptide content of sample 3/average Peptide
content in sample1+ sample 2 × 100).
Chemo- and optogenetics design. Chemo- and optogenetic experiments targeting
the OXT system were only performed in GH rats. After stereotaxic virus infusion
into the PVN and SON, animals were kept single-housed for 1 week to recover.
Thereafter, they were again group-housed for 2 weeks until either the experiment
took place (chemogenetic) or they had their optical fiber implanted (optogenetic).
Similarly to the pharmacologal experiments, chemogenetic rats were kept in groups
and isolated shortly before the dark phase (see above). Subjects received an i.p.
infusion of clozapine-N-oxide dihydrochloride (CNO, 2 mg/kg) 45 min before the
FIT. They were brought back to their original groups directly after the FIT.
Importantly, for those experiments, we had three control groups: (i) subjects
infected with a control rAAV1/2 OXTpr-mCherry into the PVN and SON, which
received CNO (virus control), non-infected rats who received either (ii) CNO or
(iii) saline infusions (drug control). Since there was no difference among the levels
of aggression displayed by those three groups (not shown) they were pooled
together in a single control group depicted in gray in Fig. 3g. In the optogenetic
experiments, after optical fiber implantation rats were single-housed for three days
for recovery and to avoid damaging the fiber. Similarly to the microdialysis
experiments, both controls and ChR2 animals were connected to the optogenetic
cables two hours before the experiment to get used to the cables. In this experi-
ment, the FIT lasted 12 min. Blue-light stimulation (30 ms pulses of 30 Hz deliv-
ered for 2 min; in analogy to Knobloch et al., 2012) was delivered at the 2nd and
again 8th minute after the beginning of the FIT. Here, controls consisted of animals
infected with a control rAAV1/2 OXTpr-mCherry into the PVN and SON. For
both, chemo- and optogenetic experiments, animals were tested twice at different
phases of their estrous cycle: once in proestrus/estrus, and once in metestrus/
diestrus. All animals were transcardially perfused with paraformaldehyde (PFA 4%)
for histological verification of the specificity of viral infections after the last test.
Although the i.c.v. and local pharmacology experiments showed robust serenic
effects of AVP (Figs. 3 and 5), we decided to not genetically manipulate the AVP
system centrally or locally due to the following reasons: (i) AVP is one of the main
players in brain physiology and stimulation of several cell bodies in different brain
regions especially in the hypothalamus could disturb homeostasis. In fact, high
doses of i.c.v. AVP are known to elicit barrel rotations in rats66. (ii) AVP neurons
are widespread in several nuclei in the rat brain such as the medial amygdala, the
BNST, PVN, and SON67, which makes the infusion of all targeted neurons
challenging in terms of animal welfare. (iii) We (data not shown) and others68 have
found low specificity of the AVP directed virus to infect intra- and
extrahypothalamic parvocellular AVP neurons, which are known to project to the
LS67.
Neuronal activation after aggression. To compare neuronal activity patterns in the
dLS and vLS of IST and GH rats after exposure to the FIT, we used female Venus-
VGAT rats (10–14 weeks old). Immediately after FIT exposure rats were deeply
anesthetized with isoflurane (ForeneH, Abbott GmbH & Co. KG, Wiesbaden,
Germany), followed by CO2, transcardially perfused, and brains were harvested for
subsequent immunohistochemistry stainings (behavioral data in Supplementary
Data 2–3).
Delimitation of the dLS and vLS. The subregions of the LS were delimitated using
the Paxinos rat atlas together with the receptor binding pattern of OXTRs and
V1aRs as a reference.
Stereotaxic surgery. Rats were anesthetized with isoflurane, injected i.p. with the
analgesic Buprenovet (0.05 mg/kg Buprenorphine, Bayer, Germany) and the anti-
biotic Baytril (10 mg/kg Enrofloxacin, Baytril, Bayer, Germany), and fixed in a
stereotaxic frame. I.c.v. guide cannulas (21 G, 12 mm; Injecta GmbH, Germany)
and microdialysis probes (self-made, molecular cutoff 18 kDa22) were implanted
unilaterally, whereas local guide cannulas (25 G, 12 mm; Injecta GmbH, Germany)
were implanted bilaterally. All cannulas were implanted 2 mm above the target
region to avoid lesion of the target region, whereas microdialysis probes had to be
implanted directly into the target region, fixed to the skull with two jeweler’s screws
and dental cement (Kallocryl, Speiko-Dr. Speier GmbH, Muenster, Germany). The
cannulas were closed by a stainless steel stylet (i.c.v. 25 G, local 27 G).
For viral infection in chemo- and optogenetic experiments, a solution of
ketamine (100 mg/kg, Medistar, Germany) and xylazine (10 mg/kg, Medistar,
Germany) was applied i.p. as anesthesia. After virus delivery, the skin was sutured.
For optogenetic experiments, rats were implanted with the optic fiber (PlexBright
optogenetic stimulation system fiber stub implant; 6 mm length) into the vLS, fixed
to the skull with two jeweler’s screws and dental cement as described above 21 days
after viral infection and 2 days prior to the experiment. For specific coordinates
please see Supplementary Table 1.
Receptor autoradiography. Brains were cryo-cut into 16-µm coronal sections,
slide-mounted, and stored at −20 °C. The receptor autoradiography procedure was
performed using a linear V1aR antagonist [125I]-d(CH2)5(Tyr[Me])-AVP (Perkin
Elmer, USA) or a linear OXTR antagonist [125I]-d(CH2)5[Tyr(Me)2-Tyr-Nh2]9-
OVT (Perkin Elmer, USA) as tracers. In brief, the slides were thawed and dried at
room temperature followed by a short fixation in paraformaldehyde (0.1%). Then
slides were washed two times in 50 mM Tris (pH 7.4), exposed to tracer buffer (50
pM tracer, 50 mM Tris, 10 mM MgCl2, 0.01% bovine serum albumin) for 60 min,
and washed four times in Tris buffer 10 mM MgCl2. The slides were then shortly
dipped in pure water and dried at room temperature overnight. On the following
day, slides were exposed to Biomax MR films for 7–25 days depending on the
receptor density and brain region (Kodak, Cedex, France). The films were scanned
using an EPSON Perfection V800 Scanner (Epson, Germany). The optical density
of V1aR and OXTR binding was measured using ImageJ (V1.37i, National Institute
of Health, http://rsb.info.nih.gov/ij/). Receptor density was calculated by sampling
the whole region of interest, average gray density was calculated after subtracting
the tissue background data was posteriorly converted to relative optical density as
previously described69. Bilateral measurements of 6–12 brain sections per region of
interest were analyzed for each animal, thus data points represent the mean of
those measurements.
ELISA for plasma corticosterone. Quantification of plasma corticosterone was
performed using enzyme-linked immunosorbent assay (ELISA). As described
before, trunk blood of FIT animals was collected after decapitation. Approximately
1 ml blood was collected in EDTA-coated tubes on ice (Sarstedt, Numbrecht,
Germany), centrifuged at 4 °C (2000 × g, 10 min), aliquoted and stored at −20 °C
until the assay was performed using a commercially available ELISA kit for cor-
ticosterone (IBL International, Hamburg, Germany) following the manufacturer’s
protocol.
Radioimmunoassay for OXT and AVP. OXT and AVP content in extracted blood
and CSF, and lyophilized microdialysates was measured using a sensitive and
specific radioimmunoassay (RIAgnosis, Germany; sensitivity: 0.3 pg/sample cross-
reacitivity: <0.7%). All samples were measured within the same assay to avoid
inter-assay variability.
Drugs and viruses. Animals were treated either with endogenous ligands, agonists,
or antagonists to modulate the OXT and AVP systems. Usually, drugs were infused
10 min before the FIT in i.c.v. experiments (OXT: 50 ng/5 µl AVP: 0.1 ng or 1 ng/5
µl, Tocris, Germany). Antagonists were infused 10 min prior to the infusion of the
respective agonist with a final volume (agonist+ antagonist) of 5 µl (OXTR-A, des-
Gly-NH2,d(CH2)5[Tyr(Me)2,Thr4]OVT; V1aR-A, d(CH2)5Tyr(Me)2AVP: 750
ng)37. For cannulas placed in the LS, agonists (OXT, AVP, TGOT, [Thr4,Gly7]OT:
0.1 ng/0.5 µl per side) were infused 5 min before the FIT, whereas antagonists
(OXTR-A and V1aR-A: 100 ng/0.5 µl, per side) and muscimol (10 ng/0.5 µl, per
side, Tocris) were infused 10 min before the FIT. In order to modulate the activity
of the OXT neurons, the PVN and SON of GH females were infused with 280 nl of
rAAV1/2 OTprhM3Dq:mCherry (4 × 1011 genomic copies per ml) and rAAV1/2
OXTpr-ChR2:mCherry (4 × 1011 genomic copies per ml) for chemo- and opto-
genetic experiments, respectively. Viruses were slowly infused by manual pressure
infusion at 70 nl/min. After infusion, injected optogenetic animals had their water
replaced by salt loaded water for 1 week (2% NaCl) to enhance virus infection and
expression. Chemogenetic animals received i.p. infusions either with CNO
(HB6149, HelloBio, United Kingdom) or 0.9% saline (1 ml/kg).
Patch-clamp
Slice preparation. Juvenile VGAT rats (postnatal days 15–21) were deeply anes-
thetized with isoflurane and decapitated. Coronal brain slices containing the LS
(300 µm) were cut in ice-cold carbogenized (O2 [95 %], CO2 [5 %]) artificial
extracellular fluid (aCSF; [mM]: 125 NaCl, 26 NaHCO3, 1.25 NaH2PO4, 20 Glu-
cose, 2.5 KCl, 1 MgCl2, and 2 CaCl2) using a vibratome (Vibracut, Leica Biosys-
tems, Germany) followed by incubation in carbogenized aCSF for 30 min at 36 °C
and then kept at room temperature (~21 °C) until experimentation.
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Electrophysiology. Neurons in the dLS and vLS were visualized by infrared gradient-
contrast illumination via an IR filter (Hoya, Tokyo, Japan) and patched with
pipettes sized 8–10MΩ. Somatic whole-cell patch-clamp recordings were per-
formed with an EPC-10 (HEKA, Lambrecht, Germany). Series resistances mea-
sured 10–30MΩ. The intracellular solution contained [mM]: 110 CsCl, 10 HEPES,
4 MgCl2, 10 TEA, 10 QX-314, 2.5 Na2ATP, 0.4 NaGTP, 10 NaPhosphocreatine, 2
ascorbate, at pH 7.2. In addition, biocytin (5 mg/ml) was added to the intracellular
solution for post hoc fluorescent labeling of the patched neurons. The bath aCSF
(see above) in the experimental chamber was gassed with carbogen and kept at
room temperature. The average resting potential of lateral septal neurons was −60
omV42. Leaky cells with a holding current beyond <−30 pA were not further used
for experimentation. Spontaneous activity (i.e., sIPSCs) was recorded in voltage-
clamp mode at resting membrane potential (−60 mV). The frequency and
amplitude of sIPSCs were analyzed with Origin 2019 (OriginLab Corporation,
Northampton, MA, USA).
Histology. After the experiment in vitro slices were post-fixed in 4% paraf-
ormaldehyde in PBS (4 °C, overnight) and prepared for fluorescent labeling.
Perfusion. After deep anesthesia with isoflurane followed by CO2 rats were
transcardially perfused first with 0.1 phosphate-buffered saline (PBS) followed by
4% PFA. Brains were post-fixed in 4% PFA (4 °C, overnight).
Immunohistochemistry. Brains were cut into 40 µm slices, which were collected in
cryoprotectant solution and stored at −20 °C until usage. Typically, a series of
6–8 slices comprehending the whole anteroposterior axis of the region of interest
were used for immunostaining. First, slices were washed in 0.1 PBS and then rinsed
in Glycine buffer (0.1 M in PBS) for 20min. Afterwards, slices were washed with
PBST (0.1 PBS with 0.3% triton-x 100) and blocked for 1 h in blocking solution.
Directly after blocking, slices were incubated in primary antibodies for 1–2 h at
room temperature and then at 4 °C overnight. On the next day, slices were again left
in room temperature for 1–2 h, washed in PBST and incubated with the secondary
antibody. Next, slices were rinsed in 0.1 PBS and mounted on adhesive microscope
slides (Superfrost Plus, Thermo Fisher Scientific Inc, USA). Slides were kept in the
dark at 4 °C until imaging. Especially, for the pERK immunostaining slices were pre-
incubate in ice-cold methanol at −20 °C for 10min before the Glycine buffer step.
Also for this staining primary antibody incubation lasted 64 h. For details on tissue,
mounting medium, blocking solution, and antibodies, please see Supplementary
Table 2. Imaging from the neural activity, patch-clamp, and molecular identification
of the LS neurons was done using an inverted confocal laser scanning microscope
(Leica TCS SP8, Leica Microsystems, Wetzlar, Germany). Chemo- and optogenetic
imaging was performed using an epi-fluorescence microscope (Thunder Imaging
Systems, Leica). Digital images were processed (Merging and Z-projections) using
the Leica Application Suite X (Leica) and Fiji70. Cell counting was done by an
experienced observer blind to the treatments. For patch-clamp, the detailed mor-
phology of the neurites was reconstructed and analyzed from the z-stack with the
Fiji plugin Simple Neurite Tracer71. From this analysis, the number of branch
points, and total branch length of the neurites as well as the area of the soma were
extracted and compared between dorsal and ventral neurons of the LS.
Statistics. Data normality was tested using the Kolmogorov–Smirnov test. If
normality was reached, data were analyzed using either Student’s t test (paired or
unpaired), chi-square test, or analyses of variance (one or two-way analysis of
variance) followed by a post hoc comparison corrected with Bonferroni, when
appropriate. In case data were not normally distributed, either Mann–Whitney U
test or Dunn’s multiple comparison tests were performed. For detailed statistics
information see Supplementary Data 1–3.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Further information and requests for resources, supporting, and source data will be
fulfilled by the corresponding author I.N. Source data are provided with this paper.
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